Skip to content

Clinical Trial of Immediate Skin to Skin Contact at Birth Early vs. Immediate (CPPITLH)

Randomized Clinical Trial of Immediate Skin to Skin Contact (SSC) at Birth, Early vs. Immediate, on the Duration of Exclusive Human Lactation in Full-term Newborns Treated at the Universidad de La Sabana Clinic

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02687685
Acronym
CPPITLH
Enrollment
300
Registered
2016-02-22
Start date
2018-09-30
Completion date
2020-03-31
Last updated
2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Feeding

Keywords

Skin to Skin Contact, Infant, Newborn

Brief summary

SUMMARY: Human lactation is a simple, cost-effective strategy contributing to infant and maternal mortality control. Skin to skin contact (SSC), is an immediate postpartum period strategy that has proven to benefit the initiation and continuation of human lactation and decreased hospitalization during the first week of life. This study aims to determine the effect of the initiation of SSC at birth (immediate vs. early) in healthy, full term newborns treated at Universidad de La Sabana Clinic, on the duration of exclusive human lactation. Research question: What is the effect of immediate SSC at birth (immediate vs. early) on the duration of exclusive human lactation in full-term newborns treated at the Universidad de La Sabana Clinic? Methodology: A random blind clinical trial was performed in which full-term healthy newborns that are attended at the Universidad de La Sabana Clinic are included. The blind participants will be those persons measuring the results and analysing the data. The sample size is calculated for a type I error of 5%, a two tailed type II error of 20%, therefore estimating percentage losses of 30%; 150 infants were included per group. Randomization will be performed using permuted, size 6 blocks. Descriptive analysis will be conducted using central tendency and dispersion measurements. A bivariate analysis will be performed to determine which variables are associated with exclusive human lactation at 6 months. For continuous variables, the Student t- test will be used for independent samples or the Wilcoxon rank sum test, in case the assumptions of normality for the t-tests are not fulfilled. The assumption of normality will be evaluated with the Shapiro Wilk and Kolmogorov-Smirnov test. Categorical variables in contingency tables will be constructed, assessing independence between variables with the Chi-square test or Fisher's exact test when the assumption of the number of cases is not met by the cells in the contingency tables, times two. It will be calculated as a measurement of the effect of relative risk (RR) with confidence intervals; the adjusted measurements will be calculated using a multivaried regression Poisson model, variables with significant results will be used in the bivariate analysis and those with biological plausibility used for the adjustment. The analysis will be carried out for a two-tailed type I error level of 5%. The Stata 11 program will be used for the data analysis. An interim analysis will be performed upon submission of half of the expected events (106), setting limits for early termination of the trial according to the method proposed by Pampallona and Tsiatis (1994). Intervention: There will be 2 SSC randomization groups, early vs. immediate. After completing the neonatal adaptation process and according to the group assignment, it will proceed to leave the newborn with the mother in accommodation. Prior to discharge, the IBFAT scale will be applied. Monitoring will initially be performed with a face valuation between 3 and 10 days of life, then monthly telephone calls for 6 months to verify the status of human lactation. Results: To determine whether early versus immediate SSC has an impact on the duration of exclusive human lactation.

Interventions

OTHERSkin to skin contact immediate

Immediate SSC (intervention group) At birth, the baby will be dried and placed at the mother's breast where thermoregulation maneuvers will be applied and, once cord clamping has taken place, the baby will be left in SSC with the mother where the immediate neonatal adaptation interventions will take place. Mother and baby will be left in SSC for at least 1 h or until the baby has completed its first lactation properly. Once completed, the baby will be taken to the heat lamp to perform and complete all the newborn mediate adaptation interventions. If the mother expresses the desire to continue in SSC, this will be allowed again after these interventions. During immediate SSC, mother and baby will receive continuous monitoring by the health staff.

OTHERskin to skin contact early

Early SSC group (control group) At birth, the baby will be dried and placed on the abdomen and chest of their mother where thermoregulation maneuvers are applied once cord clamping has been completed. At this time, the baby will placed under the radiant heat lamp in order to complete all newborn adaptation interventions. Once stable, the mother and the baby will proceed with the initiation of SSC for at least 1 h or until the baby has completed the first lactation adequately; SSC will be allowed to continue if the mother expresses a desire to do so. During SSC, the mother and baby will receive monitoring by health personnel. All adaptation interventions, mediate and immediate, in the newborn will take place under the radiant heat lamp during the first postnatal hour.

Sponsors

Universidad de la Sabana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 60 Minutes
Healthy volunteers
No

Inclusion criteria

* Infants of mothers who express before the birth, their desire to breastfeed their newborn baby. * Infants born between 7:00 am and 5:00 pm Monday through Friday in the USC. * Full-term newborns defined by obstetric method and confirmed by paediatric method (Ballard), between 37 and 42 weeks of gestation, with appropriate weight for gestational age (between 10th and 90th percentiles for gestational age). * Vaginal birth. * Do not require basic or advanced neonatal resuscitation manoeuvres. * Healthy and stable cardiorespiratory at birth. * Have been permitted to room with the mother.

Exclusion criteria

* Mothers and newborns that present absolute or relative contraindications for human lactation. * Multiple births and pregnancies. * Mothers with postpartum complications that limit the onset of human lactation. * Major congenital malformations that prevent human lactation.

Design outcomes

Primary

MeasureTime frameDescription
Exclusive human lactationThrough study completion, an average of 6 monthsExclusive human lactation for 3 or more months. Exclusive human lactation is defined as: the time in months of human lactation as the only food source without having received other liquids or solid foods (except drugs and / or vitamins)

Secondary

MeasureTime frameDescription
Human lactation capacity in the newbornwithin the first 24 hours of lifeHuman lactation capacity in the newborn within the first 24 hours of life by IBFAT Scale
Maternal satisfaction with breastfeedingFirst 24 hoursMaternal satisfaction with breastfeeding in the first 24 hours according to the IBFAT Scale
Evolution of birth weightFirst week of lifeEvolution of birth weight in the first week of life.
The need for hospitalization in the neonatal care unitFirst week of lifeThe need for hospitalization in the neonatal care unit in the first week of life.

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026